Kim Brackenborough

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 300 citations

Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania

Roberto Arban, Gabriella Maraia, Kim Brackenborough et al. · Behavioural Brain Research · 2004 · 89 citations

Psychiatry, Medicine, Psychotropic Medication +8

An animal model of chronic inflammatory pain: Pharmacological and temporal differentiation from acute models

Alex Wilson, Stephen J. Medhurst, Claire I. Dixon et al. · European Journal of Pain · 2005 · 76 citations

Acute Pain, Chronic Inflammatory Pain, Pain Medicine +19

A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: Pharmacological validation with R-(−)-deprenyl

Leann P. Quinn, M.J. Perren, Kim Brackenborough et al. · Journal of Neuroscience Methods · 2007 · 39 citations

Molecular Pharmacology, Beam-walking Apparatus, Behavioral Neuroscience +9

Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists

David M. Wilson, James Apps, Nicholas Bailey et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 25 citations · Full text

Molecular Pharmacology, Pharmacological Study, Clinical Candidates +7